Article Versions Notes

Mabrouk N, Racoeur C, Shan J, Massot A, Ghione S, Privat M, Dondaine L, Ballot E, Truntzer C, Boidot R, et al. GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC. Cancers. 2023; 15(12):3129. https://doi.org/10.3390/cancers15123129

Mabrouk, Nesrine, Cindy Racoeur, Jingxuan Shan, Aurélie Massot, Silvia Ghione, Malorie Privat, Lucile Dondaine, Elise Ballot, Caroline Truntzer, Romain Boidot, and et al. 2023. "GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC" Cancers 15, no. 12: 3129. https://doi.org/10.3390/cancers15123129

Mabrouk, N., Racoeur, C., Shan, J., Massot, A., Ghione, S., Privat, M., Dondaine, L., Ballot, E., Truntzer, C., Boidot, R., Hermetet, F., Derangère, V., Bruchard, M., Végran, F., Chouchane, L., Ghiringhelli, F., Bettaieb, A., & Paul, C. (2023). GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC. Cancers, 15(12), 3129. https://doi.org/10.3390/cancers15123129